Areas of Expertise and Treatments
Chemotherapy uses anti-cancer medicines to destroy or control cancer cells and may be given alone or combined with other oncology treatments depending on the cancer type, stage and treatment goal.
High-dose chemotherapy uses intensive anti-cancer treatment in selected patients and may be combined with stem cell or bone marrow transplantation when clinically appropriate.
Immunotherapy helps the immune system recognise or attack cancer cells and may be used for selected cancers according to tumour characteristics, biomarkers and treatment indications.
Targeted therapy uses medicines designed to act on specific molecular changes or pathways that contribute to cancer growth and survival.
Autologous bone marrow or stem cell transplantation uses the patient's own collected stem cells to restore bone marrow function following intensive cancer treatment.
Allogeneic bone marrow transplantation uses stem cells obtained from a suitable donor and may be considered for selected blood cancers and bone marrow disorders.
Peripheral stem cell transplantation uses blood-forming stem cells collected from the bloodstream and may form part of treatment for selected haematological cancers.
Medical treatment for breast cancer may involve chemotherapy, targeted therapy, immunotherapy or hormone-based systemic treatment depending on tumour biology and disease stage.
Medical oncology treatment for colon cancer may include chemotherapy, targeted therapy or other systemic treatments depending on tumour stage, molecular profile and previous treatment.
Systemic treatment for stomach cancer may involve chemotherapy, targeted agents and other personalised oncology treatments depending on cancer characteristics and clinical stage.
Medical oncology may form part of multidisciplinary treatment for oral cancers, particularly when systemic therapy is required before, during or after local cancer treatment.
Medical treatment for lung cancer may include chemotherapy, targeted therapy and immunotherapy selected according to cancer type, stage, molecular mutations and biomarkers.
Leukemia treatment may involve chemotherapy, targeted medicines, immunotherapy and stem cell transplantation depending on the exact leukemia subtype and individual clinical factors.
Lymphoma treatment is selected according to lymphoma subtype and stage and may include systemic medicines, immunotherapy and transplantation in selected cases.
Multiple myeloma treatment may involve combination systemic therapy, targeted medicines and autologous stem cell transplantation in appropriately selected patients.
Medical oncology treatment for adult solid tumours uses systemic therapies selected according to tumour type, stage, molecular characteristics and overall patient health.
Paediatric solid tumour treatment requires age-appropriate multidisciplinary cancer care and may include chemotherapy and other systemic oncology treatments according to tumour type and stage.